352 related articles for article (PubMed ID: 19085183)
21. Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
Exp Clin Endocrinol Diabetes; 1995; 103(2):123-5. PubMed ID: 7553076
[TBL] [Abstract][Full Text] [Related]
22. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
[TBL] [Abstract][Full Text] [Related]
23. The diabetic antigen glutamic acid decarboxylase (GAD 65) in the human peripheral blood.
Tilz GP; Dausset J; Wiltgen M
Int Arch Allergy Immunol; 2010; 152(2):184-94. PubMed ID: 20016201
[TBL] [Abstract][Full Text] [Related]
24. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
[TBL] [Abstract][Full Text] [Related]
25. Structural biology of the GAD autoantigen.
Fenalti G; Buckle AM
Autoimmun Rev; 2010 Jan; 9(3):148-52. PubMed ID: 19465164
[TBL] [Abstract][Full Text] [Related]
26. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
Huang YY; Huang P; Lou HL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
[TBL] [Abstract][Full Text] [Related]
27. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies in Type 1 diabetes.
Schmidt KD; Valeri C; Leslie RD
Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
[TBL] [Abstract][Full Text] [Related]
29. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
[TBL] [Abstract][Full Text] [Related]
30. Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.
Trigwell SM; Radford PM; Page SR; Loweth AC; James RF; Morgan NG; Todd I
Clin Exp Immunol; 2001 Nov; 126(2):242-9. PubMed ID: 11703367
[TBL] [Abstract][Full Text] [Related]
31. Frequency of glutamic acid decarboxylase autoantibodies in Mexican diabetic children.
Mendoza-Morfín F; Curiel-Pérez MO; Cárdenas-Tirado H; Montero-González P; Gutiérrez-Avila C; Bravo-Ríos LE; Cárdenas-Cornejo I; Normandía-Almeida MA
Rev Invest Clin; 2000; 52(4):427-31. PubMed ID: 11061105
[TBL] [Abstract][Full Text] [Related]
32. [The demonstration and specificity of autoreactive T-lymphocytes in type-1 diabetes].
Lohmann T; Scherbaum WA
Dtsch Med Wochenschr; 1997 Jun; 122(23):737-42. PubMed ID: 9229550
[TBL] [Abstract][Full Text] [Related]
33. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
Daw K; Powers AC
Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
[TBL] [Abstract][Full Text] [Related]
34. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Davison LJ; Weenink SM; Christie MR; Herrtage ME; Catchpole B
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):83-90. PubMed ID: 18706702
[TBL] [Abstract][Full Text] [Related]
36. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
37. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes.
Mayr A; Schlosser M; Grober N; Kenk H; Ziegler AG; Bonifacio E; Achenbach P
Diabetes; 2007 Jun; 56(6):1527-33. PubMed ID: 17325256
[TBL] [Abstract][Full Text] [Related]
38. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
[TBL] [Abstract][Full Text] [Related]
39. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
